All Episodes

Sunil Verma on ADCs, AstraZeneca, and Eliminating Cancer as a Cause of Death

Beyond Survival: The Architecture of Cancer Immunotherapies

David Fajgenbaum: Surviving Castleman Disease and Reinventing Drug Discovery with AI

Sushil Patel, CEO of Replimune: The Future of Cancer Immunotherapy

Why Sean Parker Took on Cancer: Funding Risk, Failure, and Real Progress

Dan MacHugh: From Bench to Boardroom

Leading at Every Altitude

Everything Is Changing Everywhere | Daniel Arbess on Institutional Innovation in Healthcare

Endpoints, Resistance, and the Architecture of Evidence in Immuno-Oncology

The Mission is the Boss

AI in Oncology: Hype, Evidence, and the Threshold of Clinical Trust